|
| Status |
Public on Jun 12, 2022 |
| Title |
NKD180900303 |
| Sample type |
SRA |
| |
|
| Source name |
tumour
|
| Organism |
Mus musculus |
| Characteristics |
tissue: tumour
age: 8-9 weeks
gender: f
group: NR
tumour type: AB1
strain: balb/c
timepoint: d0
|
| Treatment protocol |
MIce were treated 1 hour AFTER sample collected: 100ug anti-CTLA4 + anti-PDL1 i.p.
|
| Growth protocol |
Subcutaneous tumour
|
| Extracted molecule |
polyA RNA |
| Extraction protocol |
gentleMACS system (Miltenyi Biotec)
Chromium Single Cell 3′ Libraries
|
| |
|
| Library strategy |
RNA-Seq |
| Library source |
transcriptomic |
| Library selection |
cDNA |
| Instrument model |
Illumina HiSeq 2000 |
| |
|
| Data processing |
cellranger: --expect-cells 60000
Supplementary_files_format_and_content: cellranger3 output - cellranger3 filtered matrices, containing cell barcodes, genes (feature), and count matrices in mtx format
|
| |
|
| Submission date |
Oct 06, 2020 |
| Last update date |
Jun 12, 2022 |
| Contact name |
Wee Loong Chin |
| Organization name |
National Centre For Asbestos Related Diseases
|
| Street address |
Level 5, Qq Block, Qeii Medical Centre 6 Verdun St, Nedlands
|
| City |
Perth |
| ZIP/Postal code |
6009 |
| Country |
Australia |
| |
|
| Platform ID |
GPL13112 |
| Series (2) |
| GSE153942 |
Dynamic IFNβ signalling underlies treatment response to immune checkpoint therapy in cancer [single-cell RNA-seq] |
| GSE153943 |
Dynamic IFNβ signalling underlies treatment response to immune checkpoint therapy in cancer |
|
| Relations |
| BioSample |
SAMN15420751 |
| SRA |
SRX8725071 |
